30:4D-17.16 Definitions.
142 words·~1 min read·
/nj/title-30/chapter-4d/30-4d-17-16·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
1. As used in this act:
"Beneficiary" means a person participating in a State pharmaceutical benefits program.
"Board" means the Drug Utilization Review Board established pursuant to section 2 of P.L.1998, c.41 (C.30:4D-17.17a) in connection with State pharmaceutical benefits programs.
"Compendia" means those resources widely accepted by the medical profession in the efficacious use of drugs which is based on, but not limited to, these sources: the "American Hospital Formulary Services Drug Information," the "U.S. Pharmacopeia-Drug Information," the "American Medical Association Drug Evaluations," and the peer-reviewed medical literature, and information provided from the manufacturers of drug products.
"Criteria" means those explicit and predetermined elements that are used to assess or measure drug use on an ongoing basis to determine if the use is appropriate, medically necessary, and not likely to result in adverse medical outcomes.
"Department" means the Department of Human Services.